Here we demonstrate that the use of full-length tau substrates or mixture thereof can detect multiple tauopathies in hope that these findings will contribute to the further development of seeded amplification approaches for early detection of AD and other tauopathies. The gene discussed is MAPT; the disease is Alzheimer disease.